FDA Study: More Reasons to Decline Osteoporosis Drugs

October 18, 2012 by  
Filed under Osteoporosis

 

 

The May 9, 2012 article published in the NY Times titled “Well; FDA Is Wary Of Lengthy Use Of Bone Drugs,” by Tara Parker-Pope, suggests that the FDA’s newest study may have made many women and doctors think twice about using Fosamax or its relatives to treat osteoporosis. This article was printed on the heels of a published analysis by The Food and Drug Administration urging caution about long-term use of these osteoporosis drugs. The long-term safety of bone drugs has become more and more a concern among those who prescribe them, yet the pharmaceutical companies continue to have their products be on the top of most doctors’ recommended list for osteoporosis treatment. Now that the F.D.A.’s own analysis finds¬† little, if any benefit from the drugs after three to five years of use, it will be interesting to see if there is a change in this trend.

There are healthy ways to address osteoporosis, and even reverse bone loss. This news often surprises people given the propensity for doctors to prescribe bisphosphonates and the marketing campaigns of drug manufacturers that say you can only prevent bone fractures by using their products. However, the truth is that a natural approach to bone health that includes good nutrition and exercise, can strengthen bone and reverse bone loss even if you have already been diagnosed with osteoporosis.

 

 

Comments

Tell us what you're thinking...